Histamine, leukotriene-C 4 , IL-4 and IL-13 are major mediators of allergy and asthma. They are all formed by basophils and are released in particularly large quantities after stimulation with IL-3. Here we show that supernatants of activated mast cells or IL-3 qualitatively change the make-up of granules of human basophils by inducing de-novo synthesis of granzyme B (GzmB), without induction of other granule proteins expressed by cytotoxic lymphocytes (granzyme A, perforin). This bioactivity of IL-3 is not shared by other cytokines known to regulate the function of basophils or lymphocytes. The IL-3 effect is restricted to basophil granulocytes as no constitutive or inducible expression of GzmB is detected in eosinophils or neutrophils. GzmB is induced within 6-24 hours, sorted into the granule compartment, and released by exocytosis upon IgE-dependent and -independent activation. In vitro, there is a close parallelism between GzmB, IL-13 and leukotriene-C 4 production. In vivo, Granzyme B, but not the lymphoid granule marker granzyme A, is released 18 hours after allergen challenge of asthmatic patients in strong correlation with interleukin-13. Our study demonstrates an unexpected plasticity of the granule composition of mature basophils and suggests a role of granzyme B as a novel mediator of allergic diseases.
Introduction
The incidence of allergic diseases, such as asthma, has reached epidemic proportions in industrialized countries representing a major public health problem and economic burden [1] [2] [3] .
The pathophysiology leading to bronchial hyperreactivity, mucus secretion and tissue remodeling involves complex interactions between resident cells and leukocytes attracted at sites of inflammation 2, 3 . Local allergen provocation of allergic patients has been most useful in studying the timed events of these interactions in vivo, leading to the conclusion that the so-called late-phase reaction occurring hours after allergen exposure is most relevant for the symptoms in allergic diseases. Most studies and reviews have focused on the roles of T-cells and eosinophils 2, 3 , although 20 years ago an important involvement of basophils has been postulated based on the distinct mediator profile found immediately and late after allergen exposure 4 . Indeed, more recent studies using an antibody specific for basophil granules showed that basophils rapidly infiltrate the challenged tissue 5, 6 . Thus, basophil granulocytes should be considered as key effector cells in Th2-type immune responses and allergic inflammation [7] [8] [9] . Human basophils are also a prominent source of the mediators histamine and leukotriene C 4 (LTC 4 ) 10 , and the cytokines IL-4 and IL-13 [11] [12] [13] [14] [15] , all major players in asthma.
Like mast cells, they express high-affinity IgE-receptors and harbor histamine in their granules. We and others, however, showed that they are more closely related to eosinophils since they share many receptors for cytokines and chemokines (e.g. eotaxin-receptors, CCR3), indicating similarities in their trafficking and modes of activation 15, 16 . In murine immunology, the function of basophil-like cells has been similarly neglected 17 , although producing FcεRI+ non-B/non-T cells were described 10 years ago 18 . However, several recent studies now document the importance of murine basophils in Th2-type immune responses and chronic allergic inflammation [19] [20] [21] .
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In contrast to other granulated leukocytes, little is known about the make-up of basophil granules. The composition of granule proteins and regulation of their expression has been most thoroughly studied in neutrophils [22] [23] [24] . Developing neutrophils undergo a timed program of expression and packing of granule proteins for primary, secondary and tertiare granules. It is thus generally assumed that the composition of granule proteins of mature granulocytes is fixed once these cells leave the bone-marrow 22, 23 .
The effector functions of human basophils are strongly enhanced by IL-3, IL-5, GM-CSF and nerve growth factor (NGF) 10, [25] [26] [27] . These cytokines are released by T-cells and mast cells (MCs) and are thus found at sites of allergic inflammation 2, 3, 28, 29 . Among them, IL-3 is the most potent priming cytokine of basophils and the major regulator of IL-4 and IL-13 expression 10, 11, [13] [14] [15] 25 . Furthermore, IL-3 has the longest duration of action and can also induce phenotypic alterations of mature basophils 12, 15, [30] [31] [32] .
Addressing the question whether cytokines may affect the composition of basophil granules, we found that IL-3 strongly induces mRNA for granzyme B (GzmB), a 28 kDa serine protease thought to be restricted to the lymphoid lineage which is a major effector of granulemediated cytotoxicity 33 . IL-3 selectively promotes de-novo expression of GzmB-protein in human basophils, but not in other granulocyte-types. In vitro, GzmB is induced in basophils in parallel with IL-13, and both mediators are found in vivo in a highly correlated manner in the lavage fluids in allergic late-phase reactions after segmental allergen challenge of asthmatic patients. Thus, GzmB must be considered as a novel basophil-derived mediator of allergic inflammation.
Results

IL-3 induces granzyme B in mature blood basophils without detectable granzyme A and perforin
IL-3 promotes a rapid, strong (of three to four orders of magnitude) and reversible induction of GzmB mRNA in human basophils, as determined by TacMan quantitative RT-PCR (Table   1 ). On the level of the induction of GzmB protein, IL-3 shows a threshold effect at 0.3 ng/ml, an ED50 of 1-3 ng/ml and a plateau reached at 10 ng/ml, as determined by GzmB ELISA and western blotting of cell lysates ( Fig. 1A; for variability of GzmB expression see ( Supplementary Fig. 1 ). No GzmB was detected in basophils cultured in medium (Fig. 1A/B) , with the exception of rare cases in which a slight induction became detectable (see figures 4C and 5). As a positive control, lysates of NK-cells were included in the blots indicating that the GzmB content of IL-3-treated basophils approximates that found in NK-cells (Fig. 1B) . In contradiction with a recent report 34 , no GzmB was detected in neutrophils. To further compare the composition of granule constituents in basophils, neutrophils and NK-cells, we performed immuno-blots for neutrophil α-defensin-1/3 (HNP-1/3). As expected [22] [23] [24] , neutrophils contain high levels of HNP-1/3, in contrast to lower levels found in basophils which are unaffected by IL-3, and NK-cells which lack this peptide.
In order to examine the induction of GzmB at the population level, we used intracellular staining of GzmB analyzed by flow-cytometry. The data in figure 1C confirm the induction of GzmB by IL-3 and also show a broad distribution in the intensity of staining, indicating some heterogeneity in the capacity of basophils to express this enzyme. Searching for other markers that are up-regulated by IL-3 we identified ST2, an IL-1 receptor family member involved in Th2 responses which is preferentially expressed in murine Th2 cells [35] [36] [37] . Figure   1C shows an IL-3-induced up-regulation of ST2 resulting in a parallel shift of the entire basophil population indicating that basophils are able respond to IL-3 in a uniform manner.
Examination of GzmB subcellular localization by immuno-fluorescense microscopy revealed
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Expression of two other granule constituents of cytotoxic lymphocytes 33 , Granzyme A (GzmA) and perforin, was not detectable in basophils cultured without or with IL-3. Using several experimental approaches including flow cytometry and GzmA ELISA, no intracellular GzmA was observed in basophils above the limits of the assays (<100 pg/10 6 basophils), while blood NK-cells and, NK-92 cells, a human activated NK-cell line, contained even higher levels of GzmA than GzmB. Furthermore, no signal for perforin was detected by flow cytometry and western blotting, in contrast to NK-cells serving as positive controls. No
GzmA, GzmB and perforin could be detected in neutrophils (data not shown).
The time course of the induction of GzmB by IL-3 was examined in basophils by flowcytometry, western-blotting (not shown) and by GzmB ELISA (Figures 2A; and 3 ). GzmB was detectable after a lag period of six hours, most strongly increased between 10 and 18 hours and reached a plateau at about 24 hours.
Induced granzyme B is sorted into basophil granules and can be released in response to IgE-dependent and -independent agonists
The best evidence for sorting of GzmB into the granule compartment implies the demonstration of its release upon degranulation together with other basophil granule components, such as histamine. We thus triggered exocytosis of basophils with two potent stimuli which utilize distinct types of receptors and signaling pathways, with anti-FcεRIα to cross-link IgE-receptors or with C5a to activate the G-protein-coupled receptor CD88. Cells were incubated for various time intervals without or with IL-3 before inducing degranulation,
followed by measurements of cell-free and cell-associated histamine and GzmB ( Fig. 2A) .
Indeed, GzmB was released in response to both stimuli and the relative proportion which was mobilized appeared to increase with the time, consistent with a time-dependent sorting , and eotaxin, a selective agonist of CCR3 16 , together with histamine release and leukotriene C 4 (LTC 4 ) formation (Fig. 2B) .
Continuous granule exocytosis, granzyme B secretion, LTC 4 formation and cytokine production induced by C5a and IL-3
We previously showed, that acute priming of basophils by IL-3 permitting C5a-induced lipid mediator release and enhancing degranulation requires a preincubation with IL-3 for 5 min or more, while no effect was observed when the order of the stimuli was reversed 10 . However, prolonged culture of blood basophils with a combination of C5a and IL-3 leads to continuous formation of LTC 4 in parallel with the expression and release of high levels of IL-4 and IL-13, a phenomenon that does not depend on the order of the stimuli added, but requires, apart from the presence of IL-3, ongoing signaling through the C5a receptor [13] [14] [15] 39 . This model of a late-phase response was now used to investigate the expression and/or release of GzmB, together with histamine, LTC 4 , IL-4 and IL-13. In order to minimize the anaphylactic exocytosis of histamine in response to a bolus of C5a at 37° C, this agonist was added on ice just before culture at 37°C. We next tested the ability of several cytokines to induce the expression of GzmB in human basophils (Fig. 4A) . We chose four growth factors, IL-3, IL-5, GM-CSF and NGF, which all acutely prime basophils with similar efficacy 10, 25, 26 , as well as cytokines thought to enhance cytotoxic functions of lymphocytes (IL-2, interferon-α and interferon-γ). The efficacy of IL-3 to induce GzmB was rather unique since only weak effects were observed in response to other basophil-priming cytokines. Interestingly, "late priming" for C5a-induced LTC 4 
NK-like cytotoxicity activity of human basophils
To assess a possible functional role of GzmB, we tested whether basophils can mediate lysis of appropriate target cells. Because basophils express high levels of CD244, we used the Bcell line 721.221 which expresses CD48, the ligand for CD244, as target cells in the cytotoxicity assay 44, 45 . Figure 6 shows that basophils indeed display NK-like activity towards these target cells, albeit less strongly than NK-cells. Basophil-mediated target cell lysis is completely blocked by the pan-caspase inhibitor Z-VAD consistent with a caspasedependent killing mechanism. Importantly, the cytotoxic activity of basophils is considerably enhanced by IL-3 and can be inhibited by the GzmB-inhibitor Z-IETD, suggesting an involvement of GzmB in the cytolytic activity of IL-3 treated basophils. Figure 7A demonstrates that, indeed, GzmB and IL-13 levels, in contrast to GzmA, were increased in BAL-fluids of challenged segments after 18 hours in almost all patients, but not in the controls. In contrast to all other parameters, tryptase was increased 10 min after allergen exposure, indicating that mast cell do not release preformed GzmB. Mean GzmB concentrations were about seven times higher than those of IL-13 and the increase of both mediators was highly significant (p<0.0001 between groups by ANOVA; see Supplementary   Fig.2 ). Particularly striking for clinical human samples is the excellent correlation between IL-13 and GrzmB levels found 18 hours after challenge, in contrast to the lack of significant correlations between IL-13 and GzmA, between GzmB and GzmA, or between immediate tryptase and late GzmB levels (Fig. 7B ). The increase of IL-13 and GzmB was less consistent and pronounced 42 hours and was absent 162 hours after allergen provocation as examined in 6 and 4 patients, respectively ( Supplementary Fig.3 ). Thus, IL-13 and GzmB appear in the LPR in a highly related manner and within the same time frame.
Discussion
This study demonstrates that IL-3 can qualitatively alter the composition of granule constituents of mature human blood basophils by inducing de-novo expression of GzmB.
More preliminary data indicate that the expression of some other granule proteins may also change depending on the cytokine milieu, a further sign of the remarkable plasticity of granule protein expression of this blood granulocyte type. Thus, the notion that the granule components of blood granulocytes have a fixed cell type-dependent composition must be revised, at least for basophil granulocytes. The induction of GzmB in basophils is particularly surprising because, within the immune system, GzmB is thought to be restricted to the Functional experiments with different triggers conclusively demonstrate that GzmB is sorted, at least in part, to a granule compartment which can be mobilized in a way similar to histamine, although the extent of exocytosis of these mediators does not fully overlap. Using experimental conditions resulting in the expression of high levels of IL-4 and IL-13 together with a prolonged wave of LTC 4 formation, we found that the combination of C5a and IL-3 leads to a slow secretion of GzmB in parallel with its formation. C5a neither directly induces GzmB nor alters the amounts or kinetics of IL-3-induced GzmB production. Thus, the regulation of GzmB expression in basophils differs from that of IL-4/IL-13 which need both signals for optimal induction, and also from that of plasminogen activator inhibitor-1 which is induced by C5a alone 52 .
In allergic late-phase reactions infiltrating basophils must be activated by endogenous agonists, although activation by allergen may also play a role in chronic disease. Our previous and the present studies, therefore, focused on the effects of endogenous stimuli either alone or in combination. Particularly striking is the close correlation between leukotriene formation, IL-4 and IL-13 expression and the de-novo induction of GzmB, with regards to both the time frame and the efficacy of cytokines regulating these important functions in basophils: The most efficient cytokine inducing GzmB together with other phenotypic and functional alterations is IL-3 [30] [31] [32] . An identical concentration range of IL-3 induces GzmB expression and the persistent facilitation of LTC 4 formation. When the effect of different cytokines was compared we observed an identical order of efficacy. The same is true for the regulation of IL-4 and IL-13 expression, as shown earlier [13] [14] [15] 39 . The fact that supernatants of IgE-receptor-activated human MCs can induce GzmB expression in blood basophils further supports the pathophysiological relevance of our observations. Although this induction of GzmB is largely due to MC-derived IL-3, other mast cell cytokines may also contribute.
In agreement with these in vitro findings and further supporting a role of basophils in human asthma, we found a highly correlated increase of IL-13 and GzmB levels in the BAL-fluids of the challenged lung-segment of patients with allergic asthma 18 hours after provocation.
Thus, GzmB must be considered as a potential mediator of asthma, apart from its well established role in granule-mediated cytotoxicity of lymphocytes. There is increasing evidence that IL-13 is a key cytokine in promoting the clinical symptoms of asthma, such as bronchial hyperreactivity and mucus secretion. It is, therefore, reasonable to assume that the level of IL-13 after allergen provocation is an indicator for the severity of the local LPR. The excellent correlation between IL-13 and GzmB in the challenged segments at 18 hours together with the lack of a significant correlation between these GzmB levels and tryptase released in the immediate reaction indicates that GzmB levels reflect the intensity of the The function of GzmB has been thoroughly studied for its involvement in granule-mediated cytotoxicity. In CLs, perforin is needed to deliver GzmB into the cytosol thereby inducing apoptosis of target cells 33 . In order to find a possible functional role of GzmB induction in basophils, we tested whether basophils may be able to kill appropriate target cells, although they are not regarded as killer cells and do not express detectable perforin. Surprisingly, we find an NK-like activity which is enhanced by IL-3 and diminished by GzmB-inhibition, challenging this dogma and indicating a perforin-independent unknown killing mechanism which needs further investigation. It should be noted that membrane-active bacterial toxins and adenovirus can substitute for perforin 56 , and it is thus not impossible that a myeloid For
Materials and Methods
Cell stimuli
The complement product C5a was purified from yeast-activated human serum 10 . Anti-FcεRIα mAb 29C6, directed against the non-IgE-binding epitope of the high-affinity IgE-receptor α-chain was from Roche (Nutley, NJ). fMLP (Novabiochem, Switzerland), rhMCP-1, rhEotaxin-1 and rhNGF (Preprotech, London, England), and rhIL-2 (BD Biosciences, Switzerland) were purchased from commercial sources. rhIFN-α, rhIFN-γ, rhIL-5 were provided by Roche (Basel, Switzerland) and rhGM-CSF, rhIL-3 by Novartis (Basel, Switzerland). 14 , eosinophils and neutrophils were purified from peripheral blood of healthy adult volunteers. Briefly, venous EDTA-blood (180 ml) was collected and left to sediment in 6% dextran (Amersham, Biosiences). Leukocytes were enriched for basophils using a two-step discontinuous Percoll gradient (1.0791 and 1.0695 g/ml; Amersham, Biosiences) and further purified by negative selection using MACS basophil isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of isolated basophils ranged between 95 and 99%.
Leukocyte isolation and purification
Basophils
Following basophil depletion, remaining granulocytes (pellet fraction) were separated using a single-step Percoll gradient (1.0915 g/ml). Neutrophils and enriched eosinophils collected at the interphase and in the pellet, respectively, were subjected to erythrocyte lysis. Purified neutrophils were scarcely contaminated (<2%) with eosinophils. Eosinophils were further purified to >95% by negative selection using anti-CD16 and anti-glycophorin A magnetic beads (both from Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of isolated granulocytes was assessed by Gimsa staining.
NK-cells were purified from peripheral blood mononuclear cells (PBMC) using a negative selection kit according to the manufacturer's protocol (NK-Cell Isolation Kit-II, Miltenyi Biotec, Bergisch Gladbach, Germany). 
Culture of basophils with supernatants of human mast cells
Human mast cells were isolated from intestinal tissue obtained from healthy sections after surgery of tumour patients as described 29 . After purification using positive selection with antic-Kit-coated magnetic beads (Miltenyi Biotec), mast cells were cultured for 10 days with 100ng/ml SCF followed by two weeks with 20ng/ml IL-4 + 100ng/ml SCF. Before the collection of supernatants, mast cells (>99% purity) were washed, suspended at 1x 10 6 cells/ml in fresh medium containing SCF only, and cultured for 24 h with or without 100ng/ml anti-FcεRIα mAb. Supernatants were centrifuged through a Biomax 100K membrane (Millipore) to remove any residual anti-FcεRIα mAb and added in a 1:1 dilution to basophils (3.6x10 6 cells/ml) in fresh medium. Where indicated, mast cell supernatants were preincubated for 10 min with 10 μg/ml anti-IL-3 antibody (affinity-purified goat anti-human IL-3;
R&D).
Flow cytometry
For intracellular staining, cells were fixed and permeabilized using the Fix-and-Perm Cell Permeabilization kit (Caltag). Cells were re-suspended in PBS supplemented with 5% FCS and stained with fluorochrom-labeled mAbs: anti-GzmB-PE (mIgG1, clone GB11; Serotec), anti-GzmA-FITC (mIgG1, clone CB9), anti-perforin-FITC (mIgG2b, clone δG9), or isotype control mAbs (mIgG1, clone MOPC-21; mIgG2b, clone 27-35) (all from BD-Biosciences). For surface staining, basophils were incubated with anti-hST2 mAb (IgG1, clone B12; MBL) or control mAb (mIgG1, clone 107.3; BD-Biosciences) in PBS supplemented with 10% donor serum, followed by goat-anti-mouse IgG PE-F(ab') 2 (Serotec). Flow cytometry was performed with a FACSCalibur (BD-Biosciences). At least 5 x 10 4 events were acquired.
Western blot analysis
Proteins were precipitated out of the cell suspension with 10% trichloroacetic acid, separated 
Granzyme B mRNA measurements by RT-PCR
Total RNA was prepared from freshly isolated and cultured basophils using RNeasy-Kit (Qiagen). To generate cDNA, RNA was transcribed by SuperScript II RNase H`Reverse Transcriptase (Invitrogen). Random hexamer primers, first strand buffer and DTT were from Invitrogen, PCR Nucleotide Mix and RNAsin from Promega (Catalysis). Real-time PCR was carried out using commercially pre-designed primers and probes for GzmB (Hs00188051_m1) and PBGD (Hs00609297_m1) (Applied Biosystems). PCR was run on an ABI prism 7700 sequence detector using universal cycling conditions and data were analyzed using the Sequence Detector software from Applied Biosystems. The amount of GzmB-mRNA, normalized to an endogenous reference (PBGD) and relative to a calibrator (freshly isolated basophils), is given by 2  -ΔΔCt and designated as fold change.
Immunofluorescence
Cytospin preparations of basophils were fixed with 1.33% paraformaldehyde in saturated aqueous pikrinic acid for 10min, washed with PBS and blocked in TBS/PBS (1:1) containing 1% goat serum for 1h. Incubation with anti-GzmB mAb (20μg/ml, IgG1, Hoelzel Diagnostika, Germany) or isotype control mAb (20μg/ml, IgG1; BD-Biosciences) followed by a goat antimouse IgG Alexa-Fluor TM 488-conjugated F(ab') 2 (Molecular Probes; 1 to 1000 dilution). DNA was stained with DAPI (1μg/ml; Fluka). Images were acquired and analyzed using constant settings on a Nicon Eclipse E600 fluorescence microscope with a 60x oil objective using FITC and DAPI filter sets. (a-IL-3; 10 μg/ml) was added. An irrelevant control goat IgG had no effect on GzmB expression (data not shown). Tyr694-phosphorylation of Stat5 is shown as another independent indicator for the stimulation of basophils by mast cell-derived IL-3. Total Stat5 levels were identical under all the conditions (data not shown). 
Cytotoxicity assay
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